Clinical outcomes of first-line sunitinib followed by immunotherapy
A recent study published in Clinical Genitourinary Cancer has found [...]
Survival outcomes for patients on ipilimumab plus nivolumab combination therapy
Further results from the ongoing CheckMate 214 phase III study [...]
Survivorship and immune checkpoint inhibitors
In a study reported in the August issue of the [...]
Inflammatory biomarkers for non-metastatic kidney cancer
This study looked at inflammatory biomarkers in the blood for [...]
Activity of cabozantinib after immunotherapy in advance kidney cancer
A retrospective study published in the European Journal of Cancer [...]
Inflammatory biomarkers to predict outcomes in kidney cancer
There still remains the need for a reliable biomarker to [...]
ASCO 2020: Implications of the research presented at ASCO 2020 on the treatment of advanced kidney cancer
In this video presentation, Dr Toni Chouieri discusses the SAVOIR, [...]
Sunitinib re-challenge in patients with metastatic kidney cancer
A study published in Clinical Genitourinary Cancer looks at the [...]
Systemic therapy for the treatment of metastatic kidney cancer brain metastases
Research published in Clinical Genitourinary Cancer this month looked at the [...]
Cryoablation comparable to surgery for treating early-stage kidney cancer
A study published in the journal Radiology from John Hopkins [...]
